Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells.
about
Wnt signaling inhibitor FH535 selectively inhibits cell proliferation and potentiates imatinib-induced apoptosis in myeloid leukemia cell lines.Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer.Generating human hematopoietic stem cells in vitro -exploring endothelial to hematopoietic transition as a portal for stemness acquisition.Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation.ADAM8 Is an Antigen of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia Cells Identified by Patient-Derived Induced Pluripotent Stem Cells.Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells.
P2860
Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 October 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Discovery of survival factor f ...... nduced pluripotent stem cells.
@en
Discovery of survival factor f ...... nduced pluripotent stem cells.
@nl
type
label
Discovery of survival factor f ...... nduced pluripotent stem cells.
@en
Discovery of survival factor f ...... nduced pluripotent stem cells.
@nl
prefLabel
Discovery of survival factor f ...... nduced pluripotent stem cells.
@en
Discovery of survival factor f ...... nduced pluripotent stem cells.
@nl
P2093
P2860
P1433
P1476
Discovery of survival factor f ...... induced pluripotent stem cells
@en
P2093
Brian E McIntosh
David Yang
Igor Slukvin
James Thomson
Jean Y J Wang
Lihong Tao
Ron Stewart
Scott Swanson
Yuki Ishii
P2860
P304
P356
10.1016/J.SCR.2015.10.015
P577
2015-10-31T00:00:00Z